Archive for April, 2010

Journal of Commercial Biotechnology — April 2010 issue now available

The April 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 16, Issue 2 Editorial Case studies in innovation: What enables outstanding achievements? PDF Yali Friedman Articles Biotechnology marketing: Insider and outsider views PDF Päivi Eriksson, Heidi Rajamäki The current […]


Case studies in innovation: What enables outstanding achievements?

As promised, I have posted my observations from the 2009 Kyoto Prize. I had an opportunity to interact with each of the laureates, and focused on the question of how they were able to accomplish their exemplary achievements. It is not enough to simply be brilliant or hard-working — all their peers likely share these […]


Next DCbiotech meeting: April 14th in Bethesda, with special guest

The next DCbiotech meeting will be at the Redwood Restaurant and Bar in Bethesda, MD on April 14th 2010. Redwoods is at 7121 Bethesda Ave, and we’ll be meeting in the bar area from 6-8pm. To facilitate finding the group, you may want to check out my photo on the about page. Also, we will […]


Drug Patent Expirations in April 2010

Drug Patent Expirations in April 2010 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration HYZAAR Merck hydrochlorothiazide; losartan potassium 5,153,197*PED Apr 6, 2010 IPLEX Insmed mecasermin rinfabate recombinant 5,200,509 Apr 6, 2010 COZAAR Merck losartan potassium 5,153,197*PED Apr 6, 2010 DUODOTE Meridian Medcl atropine; pralidoxime chloride 5,092,843 Apr […]